Compare PDS & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PDS | CERT |
|---|---|---|
| Founded | 1951 | 2008 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Retail: Computer Software & Peripheral Equipment |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 918.1M | 860.9M |
| IPO Year | 1998 | 2020 |
| Metric | PDS | CERT |
|---|---|---|
| Price | $93.73 | $4.68 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 10 |
| Target Price | ★ $122.33 | $11.67 |
| AVG Volume (30 Days) | 97.9K | ★ 2.9M |
| Earning Date | 04-29-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $418,838,000.00 |
| Revenue This Year | $5.66 | $4.18 |
| Revenue Next Year | $2.31 | $5.39 |
| P/E Ratio | $884.15 | ★ N/A |
| Revenue Growth | N/A | ★ 8.75 |
| 52 Week Low | $41.95 | $4.59 |
| 52 Week High | $103.80 | $13.88 |
| Indicator | PDS | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 52.40 | 25.41 |
| Support Level | $83.72 | N/A |
| Resistance Level | $103.13 | $6.47 |
| Average True Range (ATR) | 2.83 | 0.33 |
| MACD | 0.04 | -0.17 |
| Stochastic Oscillator | 42.92 | 3.74 |
Precision Drilling Corp is a provider of contract drilling and completion and production services to oil and natural gas exploration and production companies in Canada, the United States, and certain international locations. Contract Drilling Services include drilling rigs, procurement and distribution of oilfield supplies, and the manufacture, sale and repair of drilling equipment. Completion and Production Services include service rigs, oilfield equipment rental, and camp and catering services.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.